Bariatric Surgery Combined With GLP-1 Receptor Agonists Study — Stella

stellabeta Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bariatric Surgery Combined With GLP-1 Receptor Agonists Study — Stella

Recruiting

Back to Obesity trials

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

China

China-Japan Friendship Hospital, Beijing

Key details

Phase

Safety & dosing

Sponsor

China-Japan Friendship Hospital

Enrollment target

~200 participants

Started

January 2024

Primary completion

December 2027

Age range

18 Years – 60 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov